Suchergebnisse - "Bates, Timothy A"

PubPharm (8)

1

An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants

enthalten in: JCI insight | 2023

von Bates, T. | Leier, H. | McBride, S. | +6

UpdateOf: medRxiv. 2023 Jan 04;:. - PMID 36656773

2

BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age

enthalten in: Cell reports | 2022

von Bates, T. | Lu, P. | Kang, Y. | +9

UpdateOf: medRxiv. 2022 Aug 16;:. - PMID 36032979

3

A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants

enthalten in: Nature communications | 2022

von Farley, S. | Kyle, J. | Leier, H. | +7

UpdateOf: bioRxiv. 2022 Feb 15;:. - PMID 35194611

4

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants

enthalten in: Science immunology | 2022

von Bates, T. | McBride, S. | Leier, H. | +9

5

Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection

enthalten in: JAMA | 2022

von Bates, T. | McBride, S. | Winders, B. | +4

6

Capsid-specific nanobody effects on HIV-1 assembly and infectivity

enthalten in: Virology | 2021

von Alfadhli, A. | Romanaggi, C. | Barklis, R. | +4

7

Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum

enthalten in: Nature communications | 2021

von Bates, T. | Leier, H. | Lyski, Z. | +16

UpdateOf: medRxiv. 2021 Apr 09;:. - PMID 33851185

8

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2

enthalten in: Cell reports | 2021

von Bates, T. | Weinstein, J. | Farley, S. | +3

UpdateOf: bioRxiv. 2020 Jul 30;:. - PMID 32766589

1
[1]